Venous ThromboembolismNCT00456196
Epidemiology of Venous Thromboembolism
An observational study of Venous Thromboembolism and Pulmonary Embolism, run by Brigham and Women's Hospital at 1 site in United States.
Trial summary
More than 5 years ago the DVT FREE Registry was conceived. Its database consists of 5,451 ultrasound-confirmed DVT patients from 183 institutions. This database is rich in information of critical importance to health care providers. Read more about this study
- Who is it for?
- Any age
- Conditions the study is for
- Venous Thromboembolism, Pulmonary Embolism, Cancer
- How many people
- 5,451 participants
- Where
- 1 siteUnited States
- Study dates
- Apr 2006to Jun 2009
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Study population: Patients from the DVT FREE study with ultrasound-confirmed deep vein thrombosis
Who may be able to join
- Ultrasound-confirmed DVT patients from 183 institutions.
Who cannot join
None listed.
Trial locations and contacts
1 site in 1 country.
United States1 site
Brigham and Women's Hospital
Boston, Massachusetts, 02115
About this study
Official title: Epidemiology of Venous Thromboembolism: Analyses and Publications From the DVT FREE Database
More than 5 years ago the DVT FREE Registry was conceived. Its database consists of 5,451 ultrasound-confirmed DVT patients from 183 institutions. This database is rich in information of critical importance to health care providers. The information contained within the database will be revisited to provide more detailed analyses which will be used for risk factor assessment and for decision-making regarding the implementation of VTE Prophylaxis.
Read the detailed description
BACKGROUND:
The Venous Thromboembolism (VTE) Research Group has explored and studied the epidemiology of DVT and pulmonary embolism (PE) for more than 2 decades. The earliest analyses were done with the database from the Framingham Heart Study. Subsequent analyses were undertaken using the Nurses' Health Study.
More than 5 years ago the DVT FREE Registry was conceived. The concept was to accrue broad representation of patients with ultrasound-confirmed DVT throughout the US.
The Principal Investigator began initial work on this project by developing the case report form (CRF) with Co-Investigators. After the CRF was piloted and finalized, centers were recruited for participation. The enthusiasm in response to DVT FREE was overwhelming. The initial investigators meetings were conducted by videoconference shortly after September 11, 2001. Accrual of patients occurred much more rapidly than projected. Within 6 months, 5,451 patients were enrolled with ultrasound-confirmed DVT at 183 participating institutions.
Dr. Samuel Z. Goldhaber chaired the Publications Committee. The Master Paper was published in January 2004. 3 manuscripts on subgroups and 3 manuscripts on special populations were subsequently published under Dr. Goldhaber's supervision. The subgroup papers studied upper extremity DVT, the relationship between DVT and symptomatic DVT and PE, and predictors of massive DVT. The special populations papers studied gender differences in receiving prophylaxis, utilization of vena cava filters, and pregnancy.
Though the publication record is impressive in scope, much work remains to be done. The database is rich in information of critical importance to health care providers. The information contained within the database should be analyzed to provide more detailed analyses which will be used for risk factor assessment and for decision-making regarding the implementation of VTE prophylaxis.
For the current DVT FREE publication project, we will use the database to analyze findings that will yield 8 publications in special populations: 1) medically ill hospitalized patients, 2) cancer patients, 3) nonorthopedic general surgery patients, 4) orthopedic surgery patients, 5) long-haul travel patients, 6) COPD Patients, 7) Renal Patients, and 8) Elderly Patients.
PROJECT DESCRIPTION:
- Medically Ill Hospitalized Patients: Medically ill hospitalized patients are the most important subgroup to study. These patients often do not receive guideline-recommended prophylaxis. We believe that medically ill hospitalized patients are underserved. For this DVT FREE publication, we will exclude all patients who had surgery within the past 3 months. We will also exclude women who were pregnant or postpartum. All other patients will be included in these analyses. They will be stratified according to age, height, weight, body mass index (BMI), gender, and whether they received prophylaxis.
- Cancer Patients: Cancer patients have received increasing attention because of the relationship between cancer and DVT. For example, the National Comprehensive Cancer Network (NCCN) organized a special committee to write consensus guidelines for prevention and treatment of DVT in this patient population. For this DVT FREE publication, we will include all patients with cancer. We will also include whether the cancer was active and whether the patient is receiving ongoing radiation therapy or chemotherapy. These cancer patients will be stratified according to age, height, weight, BMI, gender, and whether they received prophylaxis.
- Nonorthopedic General Surgery Patients: For this DVT FREE publication, we will include all nonorthopedic general surgery patients. These patients will have undergone surgery within the 3 months prior to DVT. We will also explore the type of surgery (excluding orthopedic surgery) and type of anesthetic that was used. These patients will be stratified according to age, height, weight, BMI, gender, and whether they received prophylaxis.
- Orthopedic Surgery Patients: For this DVT FREE publication, we will include all orthopedic surgery patients. We will also include patients who suffered hip fracture, pelvic fracture, upper extremity fracture, lower extremity fracture, or other fracture within 30 days prior to enrollment. We will also include patients with major trauma to the spine, pelvis, or upper or lower extremities. These patients will be stratified according to age, height, weight, BMI, gender, and whether they received prophylaxis.
- Congestive Heart Failure (CHF)
- COPD Patients: For this DVT FREE publication, we will include all patients with COPD. These patients will be stratified according to age, height, weight, BMI, gender, and whether they received prophylaxis.
- Renal Patients: For this DVT FREE publication, we will include all renal patients. These patients will be stratified according to age, height, weight, BMI, gender, and whether they received prophylaxis.
- Elderly Patients:
For this DVT FREE publication, we will include all elderly patients. For this study we will define elderly as 70 years of age or older. These patients will be stratified according to age, height, weight, BMI, gender, and whether they received prophylaxis.
- Conditions
- Venous Thromboembolism, Pulmonary Embolism, Cancer, Deep Vein Thrombosis, COPD
- Keywords
- COPD, Thrombosis, Cancer, Renal, Elderly, Surgery, Orthopedic Surgery, Medically Ill, Deep Vein Thrombosis, Pulmonary Embolism, Anticoagulation
- Medical subject headings
- Venous Thromboembolism, Pulmonary Embolism, Neoplasms, Venous Thrombosis, Pulmonary Disease, Chronic Obstructive, Thrombosis
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted4 Apr 2007 (estimated)
- Study startApr 2006
- Primary completionJun 2009
- Study completionJun 2009
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (4)Papers the sponsor has linked to this study.
- Other trials for Venous ThromboembolismStudies of the same condition, open and under way.
- More trials run by Brigham and Women's HospitalThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Retrospective
- Enrolment
- 5,451 participants (actual)
Sponsor and investigators
- Lead sponsor
- Brigham and Women's Hospital
- Sponsor type
- University, hospital or other
- Collaborators
- Sanofi
- Investigators
- Samuel Z. Goldhaber, MD, Principal investigator, Brigham and Women's Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT00456196
- Sponsor's protocol ID
- 2006-P-000820
- Status last verified
- Jul 2009
- First submitted
- 2 Apr 2007
- Last updated
- 13 Jul 2009
- Results posted
- No
- Data monitoring committee
- No
Publications
Joffe HV, Kucher N, Tapson VF, Goldhaber SZ; Deep Vein Thrombosis (DVT) FREE Steering Committee. Upper-extremity deep vein thrombosis: a prospective registry of 592 patients. Circulation. 2004 Sep 21;110(12):1605-11. doi: 10.1161/01.CIR.0000142289.94369.D7. Epub 2004 Sep 7.
PubMed 15353493Kucher N, Tapson VF, Goldhaber SZ; DVT FREE Steering Committee. Risk factors associated with symptomatic pulmonary embolism in a large cohort of deep vein thrombosis patients. Thromb Haemost. 2005 Mar;93(3):494-8. doi: 10.1160/TH04-09-0587.
PubMed 15735800Joffe HV, Kucher N, Tapson VF, Goldhaber SZ. Few predictors of massive deep vein thrombosis. Thromb Haemost. 2005 Nov;94(5):986-90. doi: 10.1160/TH05-05-0314.
PubMed 16363241Goldhaber SZ, Tapson VF; DVT FREE Steering Committee. A prospective registry of 5,451 patients with ultrasound-confirmed deep vein thrombosis. Am J Cardiol. 2004 Jan 15;93(2):259-62. doi: 10.1016/j.amjcard.2003.09.057.
PubMed 14715365
Study at a glance
From the registry record, last updated by the sponsor on 13 Jul 2009. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Epidemiology of Venous Thromboembolism: Analyses and Publications From the DVT FREE Database
- ClinicalTrials.gov ID
- NCT00456196
- Acronym / sponsor ID
- 2006-P-000820
- Conditions
- Venous Thromboembolism, Pulmonary Embolism, Cancer, Deep Vein Thrombosis, COPD
- Keywords
- COPD, Thrombosis, Cancer, Renal, Elderly, Surgery, Orthopedic Surgery, Medically Ill
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 5,451 participants (actual)
- Lead sponsor
- Brigham and Women's HospitalUniversity, hospital or other
- Collaborators
- Sanofi
- Study start
- Apr 2006
- Primary completion
- Jun 2009 (actual)
- Study completion
- Jun 2009 (actual)
- First posted
- 4 Apr 2007 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
More than 5 years ago the DVT FREE Registry was conceived. Its database consists of 5,451 ultrasound-confirmed DVT patients from 183 institutions. This database is rich in information of critical importance to health care providers. The information contained within the database will be revisited to provide more detailed analyses which will be used for risk factor assessment and for decision-making regarding the implementation of VTE Prophylaxis.
Detailed description
BACKGROUND:
The Venous Thromboembolism (VTE) Research Group has explored and studied the epidemiology of DVT and pulmonary embolism (PE) for more than 2 decades. The earliest analyses were done with the database from the Framingham Heart Study. Subsequent analyses were undertaken using the Nurses' Health Study.
More than 5 years ago the DVT FREE Registry was conceived. The concept was to accrue broad representation of patients with ultrasound-confirmed DVT throughout the US.
The Principal Investigator began initial work on this project by developing the case report form (CRF) with Co-Investigators. After the CRF was piloted and finalized, centers were recruited for participation. The enthusiasm in response to DVT FREE was overwhelming. The initial investigators meetings were conducted by videoconference shortly after September 11, 2001. Accrual of patients occurred much more rapidly than projected. Within 6 months, 5,451 patients were enrolled with ultrasound-confirmed DVT at 183 participating institutions.
Dr. Samuel Z. Goldhaber chaired the Publications Committee. The Master Paper was published in January 2004. 3 manuscripts on subgroups and 3 manuscripts on special populations were subsequently published under Dr. Goldhaber's supervision. The subgroup papers studied upper extremity DVT, the relationship between DVT and symptomatic DVT and PE, and predictors of massive DVT. The special populations papers studied gender differences in receiving prophylaxis, utilization of vena cava filters, and pregnancy.
Though the publication record is impressive in scope, much work remains to be done. The database is rich in information of critical importance to health care providers. The information contained within the database should be analyzed to provide more detailed analyses which will be used for risk factor assessment and for decision-making regarding the implementation of VTE prophylaxis.
For the current DVT FREE publication project, we will use the database to analyze findings that will yield 8 publications in special populations: 1) medically ill hospitalized patients, 2) cancer patients, 3) nonorthopedic general surgery patients, 4) orthopedic surgery patients, 5) long-haul travel patients, 6) COPD Patients, 7) Renal Patients, and 8) Elderly Patients.
PROJECT DESCRIPTION:
- Medically Ill Hospitalized Patients: Medically ill hospitalized patients are the most important subgroup to study. These patients often do not receive guideline-recommended prophylaxis. We believe that medically ill hospitalized patients are underserved. For this DVT FREE publication, we will exclude all patients who had surgery within the past 3 months. We will also exclude women who were pregnant or postpartum. All other patients will be included in these analyses. They will be stratified according to age, height, weight, body mass index (BMI), gender, and whether they received prophylaxis.
- Cancer Patients: Cancer patients have received increasing attention because of the relationship between cancer and DVT. For example, the National Comprehensive Cancer Network (NCCN) organized a special committee to write consensus guidelines for prevention and treatment of DVT in this patient population. For this DVT FREE publication, we will include all patients with cancer. We will also include whether the cancer was active and whether the patient is receiving ongoing radiation therapy or chemotherapy. These cancer patients will be stratified according to age, height, weight, BMI, gender, and whether they received prophylaxis.
- Nonorthopedic General Surgery Patients: For this DVT FREE publication, we will include all nonorthopedic general surgery patients. These patients will have undergone surgery within the 3 months prior to DVT. We will also explore the type of surgery (excluding orthopedic surgery) and type of anesthetic that was used. These patients will be stratified according to age, height, weight, BMI, gender, and whether they received prophylaxis.
- Orthopedic Surgery Patients: For this DVT FREE publication, we will include all orthopedic surgery patients. We will also include patients who suffered hip fracture, pelvic fracture, upper extremity fracture, lower extremity fracture, or other fracture within 30 days prior to enrollment. We will also include patients with major trauma to the spine, pelvis, or upper or lower extremities. These patients will be stratified according to age, height, weight, BMI, gender, and whether they received prophylaxis.
- Congestive Heart Failure (CHF)
- COPD Patients: For this DVT FREE publication, we will include all patients with COPD. These patients will be stratified according to age, height, weight, BMI, gender, and whether they received prophylaxis.
- Renal Patients: For this DVT FREE publication, we will include all renal patients. These patients will be stratified according to age, height, weight, BMI, gender, and whether they received prophylaxis.
- Elderly Patients:
For this DVT FREE publication, we will include all elderly patients. For this study we will define elderly as 70 years of age or older. These patients will be stratified according to age, height, weight, BMI, gender, and whether they received prophylaxis.
Study design
- Observational model
- Cohort
- Time perspective
- Retrospective
Who may qualify
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
- Study population
- Patients from the DVT FREE study with ultrasound-confirmed deep vein thrombosis
Key inclusion criteria (1 listed)
- Ultrasound-confirmed DVT patients from 183 institutions.
Key exclusion criteria (0 listed)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Not reported in the source record.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 13 Jul 2009.
- Background: PubMed 15353493Joffe HV, Kucher N, Tapson VF, Goldhaber SZ; Deep Vein Thrombosis (DVT) FREE Steering Committee. Upper-extremity deep vein thrombosis: a prospective registry of 592 patients. Circulation. 2004 Sep 21;110(12):1605-11. doi: 10.1161/01.CIR.0000142289.94369.D7. Epub 2004 Sep 7.
- Background: PubMed 15735800Kucher N, Tapson VF, Goldhaber SZ; DVT FREE Steering Committee. Risk factors associated with symptomatic pulmonary embolism in a large cohort of deep vein thrombosis patients. Thromb Haemost. 2005 Mar;93(3):494-8. doi: 10.1160/TH04-09-0587.
- Background: PubMed 16363241Joffe HV, Kucher N, Tapson VF, Goldhaber SZ. Few predictors of massive deep vein thrombosis. Thromb Haemost. 2005 Nov;94(5):986-90. doi: 10.1160/TH05-05-0314.
- Results publication: PubMed 14715365Goldhaber SZ, Tapson VF; DVT FREE Steering Committee. A prospective registry of 5,451 patients with ultrasound-confirmed deep vein thrombosis. Am J Cardiol. 2004 Jan 15;93(2):259-62. doi: 10.1016/j.amjcard.2003.09.057.
- North American Thrombosis ForumLink provided by the sponsor.
Related trials for Venous Thromboembolism
RecruitingPhase 3
REGN7508 Versus Apixaban and Enoxaparin for Thromboprophylaxis After Total Knee Arthroplasty in Adults
Venous Thromboembolism (VTE)
RecruitingPhase 3
REGN7508 Versus Acetylsalicylic Acid (ASA) for Venous Thromboprophylaxis After Total Knee Arthroplasty in Adult Participants
Symptomatic Venous Thromboembolism (VTE)
RecruitingPhase 3
REGN7508 in Adult Participants for Prevention of Cancer-Associated Thrombosis
Cancer-Associated Thrombosis (CAT)
RecruitingPhase 3
Treatment and Secondary Prevention of Venous Thromboembolism (VTE) in Adult Participants With Solid and Hematologic Cancers
Venous Thromboembolism (VTE)
Recruiting
DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis
Venous Thromboembolism, Deep Venous Thrombosis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Samuel Z. Goldhaber, MD principal investigator
Brigham and Women's Hospital
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Venous Thromboembolism and Pulmonary Embolism, run by Brigham and Women's Hospital at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 13 Jul 2009. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT00456196, which also lists 4 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Jul 2009; AzTrials last refreshed its copy on 7 Nov 2026.